Marco Jost

6.3k total citations · 2 hit papers
55 papers, 3.6k citations indexed

About

Marco Jost is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Marco Jost has authored 55 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Marco Jost's work include CRISPR and Genetic Engineering (12 papers), Angiogenesis and VEGF in Cancer (7 papers) and Porphyrin Metabolism and Disorders (6 papers). Marco Jost is often cited by papers focused on CRISPR and Genetic Engineering (12 papers), Angiogenesis and VEGF in Cancer (7 papers) and Porphyrin Metabolism and Disorders (6 papers). Marco Jost collaborates with scholars based in United States, Germany and Netherlands. Marco Jost's co-authors include Jonathan S. Weissman, Thomas M. Norman, Catherine L. Drennan, Max A. Horlbeck, Luke A. Gilbert, Ivo Buschmann, Erik Maquoi, Agnès Noël, Carol A. Gross and Britt Adamson and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marco Jost

55 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response

2016 690 citations Thomas M. Norman, Marco Jost et al. Cell profile →
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq

2022 253 citations Joseph M. Replogle, Reuben A. Saunders et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Jost United States	29	2.8k	405	369	319	298	55	3.6k
Eric H. Holmes United States	38	2.5k 0.9×	269 0.7×	452 1.2×	264 0.8×	885 3.0×	104	3.8k
Qing Jiang China	31	2.1k 0.7×	219 0.5×	382 1.0×	373 1.2×	254 0.9×	82	3.0k
Javier Muñoz Spain	30	2.7k 0.9×	464 1.1×	778 2.1×	417 1.3×	266 0.9×	97	3.8k
Georges Baffet France	35	1.6k 0.6×	421 1.0×	709 1.9×	144 0.5×	193 0.6×	73	3.7k
Zhenyue Hao Canada	20	1.6k 0.6×	313 0.8×	333 0.9×	273 0.9×	1.1k 3.7×	30	3.0k
Hyuk‐Jin Cha South Korea	29	1.7k 0.6×	364 0.9×	431 1.2×	130 0.4×	131 0.4×	117	2.5k
Michel Moenner France	27	1.6k 0.6×	430 1.1×	191 0.5×	142 0.4×	216 0.7×	52	2.6k
Rebecca Cowling United States	19	2.1k 0.7×	218 0.5×	328 0.9×	287 0.9×	113 0.4×	29	2.9k
Michael R. Schlabach United States	19	3.1k 1.1×	686 1.7×	757 2.1×	398 1.2×	263 0.9×	27	3.8k
Sandra E. Wiley United States	28	2.9k 1.0×	296 0.7×	372 1.0×	332 1.0×	387 1.3×	47	4.3k

Countries citing papers authored by Marco Jost

Since Specialization

Citations

This map shows the geographic impact of Marco Jost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Jost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Jost more than expected).

Fields of papers citing papers by Marco Jost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Jost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Jost. The network helps show where Marco Jost may publish in the future.

Co-authorship network of co-authors of Marco Jost

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Jost. A scholar is included among the top collaborators of Marco Jost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Jost. Marco Jost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Melamed, Sarah, Joshua C. Cofsky, Samuel J. Hobbs, et al.. (2025). A DNA-gated molecular guard controls bacterial Hailong anti-phage defence. Nature. 643(8072). 794–800. 5 indexed citations

Fielden, John, Sebastian M. Siegner, Markus Schröder, et al.. (2025). Comprehensive interrogation of synthetic lethality in the DNA damage response. Nature. 640(8060). 1093–1102. 10 indexed citations

Kim, Cecilia, Sunghee Bang, Nicole C. Howard, et al.. (2024). Vaginal lactobacilli produce anti-inflammatory β-carboline compounds. Cell Host & Microbe. 32(11). 1897–1909.e7. 11 indexed citations

Born, David A., et al.. (2023). Structural insight into G-protein chaperone-mediated maturation of a bacterial adenosylcobalamin-dependent mutase. Journal of Biological Chemistry. 299(9). 105109–105109. 2 indexed citations

Tolani, Bhairavi, Anna Celli, Yong Zi Tan, et al.. (2022). Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice. Nature Biotechnology. 40(12). 1834–1844. 29 indexed citations

Replogle, Joseph M., Jessica L. Bonnar, Angela N. Pogson, et al.. (2022). Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors. eLife. 11. 52 indexed citations

Replogle, Joseph M., Reuben A. Saunders, Angela N. Pogson, et al.. (2022). Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq. Cell. 185(14). 2559–2575.e28. 253 indexed citations breakdown →

Friedman, Jonathan R., Marco Jost, Justin Yamada, et al.. (2021). Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells. eLife. 10. 26 indexed citations

Jost, Marco, et al.. (2021). CRISPR-based functional genomics in human dendritic cells. eLife. 10. 22 indexed citations

10.

Jost, Marco, Yuwen Chen, Luke A. Gilbert, et al.. (2020). Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent. Molecular Cell. 79(1). 191–198.e3. 24 indexed citations

11.

Yan, Xiaowei, Nico Stuurman, Susana A. Ribeiro, et al.. (2020). High-content imaging-based pooled CRISPR screens in mammalian cells. The Journal of Cell Biology. 220(2). 47 indexed citations

12.

Jost, Marco, Reuben A. Saunders, Max A. Horlbeck, et al.. (2020). Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs. Nature Biotechnology. 38(3). 355–364. 111 indexed citations

13.

Hawkins, John S., Melanie R. Silvis, Byoung‐Mo Koo, et al.. (2020). Mismatch-CRISPRi Reveals the Co-varying Expression-Fitness Relationships of Essential Genes in Escherichia coli and Bacillus subtilis. Cell Systems. 11(5). 523–535.e9. 81 indexed citations

14.

Norman, Thomas M., Max A. Horlbeck, Joseph M. Replogle, et al.. (2019). Exploring genetic interaction manifolds constructed from rich single-cell phenotypes. Science. 365(6455). 786–793. 156 indexed citations

15.

Jost, Marco, et al.. (2016). Structure of the Catalytic Domain of the Class I Polyhydroxybutyrate Synthase from Cupriavidus necator. Journal of Biological Chemistry. 291(48). 25264–25277. 70 indexed citations

16.

Drennan, Catherine L., et al.. (2011). Flavin-Induced Oligomerization in Escherichia coli Adaptive Response Protein AidB. PMC. 1 indexed citations

17.

Hoefer, Imo E., Niels van Royen, & Marco Jost. (2006). Experimental models of arteriogenesis: differences and implications. Lab Animal. 35(2). 36–44. 11 indexed citations

18.

Schirmer, Stephan H., Ivo Buschmann, Marco Jost, et al.. (2004). Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Cardiovascular Research. 64(2). 356–364. 23 indexed citations

19.

Schütt, M., Markus K Meier, Marco Jost, & H. H. Klein. (2003). The HIV Protease Inhibitor Indinavir Impairs Glycogen Synthesis in HepG2 Hepatoma Cells. Experimental and Clinical Endocrinology & Diabetes. 111(1). 16–20. 8 indexed citations

20.

Kraus, Daniel, Mathias Faßhauer, V. Ott, et al.. (2002). Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. Journal of Endocrinology. 175(1). 185–191. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact